Document Type

Article

Publication Date

1-14-2025

Comments

This article is the author's final published version in American Journal of Obstetrics and Gynecology MFM, Volume 7, Issue 6, 2025, Article number 101605.

The published version is available at https://doi.org/10.1016/j.ajogmf.2025.101605.

Copyright © 2025 The Author(s)

Abstract

OBJECTIVE: To evaluate the effect of nitroglycerine on placenta delivery after retained placenta.

DESIGN: Systematic review with meta-analysis.

DATA SOURCES: MEDLINE, PROSPERO, Scopus, ClinicalTrials.gov, EMBASE, Sciencedirect, the Cochrane Library, Scielo were searched from their inception until February 2024.

ELIGIBILITY CRITERIA FOR SELECTING STUDIES: We included all randomized clinical trials comparing use of nitroglycerine (i.e. intervention group) with placebo or with no treatment (i.e. control group) given for retained placenta after vaginal delivery.

DATA SYNTHESIS: The primary outcome was rate of manual removal of the placenta. The summary measures were reported as relative risk (RR) or as mean difference (MD) with 95% of confidence interval (CI).

RESULTS: Four trials, including 1,279 pregnancies, were analyzed. The quality of the RCTs included was moderate. Pooled results showed that administration of nitroglycerine in women with retained placenta after vaginal delivery was associated with similar incidence of manual removal compared to control (89% vs 90%; RR 0.94, 95% CI 0.74 to 1.20). We also found similar mean postpartum blood loss, and no significant differences in the incidence of drop of hb > 15 or 30%, need for uterotonics.

CONCLUSIONS: Use of nitroglycerine in women with retained placenta after vaginal delivery did not reduce the use of manual removal of the placenta.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

39818273

Language

English

Download

Share

COinS